Posts by Sandra Ansanay-Alex
SNSF – Starting Grant
Apply before from 1 February until 5 May 2026 for the Swiss National Science Foundation Starting Grant SNSF Starting Grants 2025 represent the SNSF’s highest level of career funding. The call enables researchers to carry out their own independent project and lead a research team in Switzerland. Applicants must have several years of research…
Read MoreThe Origin of Astrocytes Revealed
A major discovery in neuroscience: a study from the Faculty of Medicine (FacMed) and the Synapsy Center at the University of Geneva uncovers that cortical astrocytes originate from two distinct progenitor cell types. Long considered a uniform support cell population, astrocytes are now recognized as diverse and essential players in brain function, involved in…
Read MoreNovochizol’s AgrINovo Partnership: Swiss-Indian Alliance for Agricultural Innovation
Indian company Aquagri, its partner, and Novochizol SA, a Valais-based startup, announced the launch of AgrINovo, a transformative collaborative project. AgrINovo aims to unlock the full potential of Novochizol technology to foster a healthier, more sustainable agriculture in India and worldwide. Novochizol™ is derived from chitosan, made from chitin, the second most abundant polysaccharide…
Read MoreSwiss Health Valley Biotechs Advance Drug Pipelines with Promising Clinical Milestones
Three innovative biotech companies based in Western Switzerland, Stalicla, Legacy Healthcare and iOnctura, have recently achieved significant progress in their therapeutic pipelines, reinforcing the region’s position as a hub for health innovation. STALICLA: Advancing Precision Medicine for Autism Geneva-based STALICLA has received the green light from the U.S. Food and Drug Administration (FDA) to initiate…
Read MoreRelief Therapeutics is preparing a reverse merger with NeuroX, the successor to MindMaze
The merger must take the form of an exchange of all NeuroX shares for newly issued shares in Relief. The transaction, which is expected to be finalised before the end of the year, would value the Geneva-based company at CHF 100 million and its future partner at CHF 1 billion. The Geneva-based pharmaceutical company…
Read MoreAzureCell Therapies and Myriad Optics Awarded by Gebert Rüf Stiftung Innobooster Programme
Two Swiss Health Valley projects, from EPFL and University of Geneva, got a CHF 150’000 Innobooster grant from Gebert Rüf Stiftung programme: AzureCell Therapies and Myriad Optics. AzureCell Therapies | Bilal Fares, University of Geneva Every 9 min, a new patient is diagnosed with Parkinson’s, a condition long considered incurable due to the irreversible loss…
Read MoreBreaking Through Cancer’s Soft Defense: A Revolutionary Swiss Approach
Swiss researchers from EPFL, University of Geneva, and HUG hospitals are pioneering a groundbreaking strategy to overcome immunotherapy resistance by targeting cancer cells’ physical properties rather than their biology. The project received a CHF 1,4 million grant from Foundation Leenaards. “Our approach targets the mechanical properties of cancer cells by making their membranes stiffer, which…
Read Moreplanetary Switzerland: Scaling Mycoprotein Production Through Strategic Expansion
Geneva-based biomanufacturing platform planetary is making significant strides in the alternative protein sector through a combination of strategic acquisitions, IP breakthroughs, retail partnerships, and government-backed expansion plans. The company has positioned itself as continental Europe’s only viable industrial mycoprotein producer, leveraging cutting-edge fermentation technology to create sustainable protein alternatives. Strategic Acquisition of Libre Foods…
Read MoreTwo UNIGE researchers receive ERC grants
Prof. Pedro Herrera and Prof. Giuseppe Iacobucci both receive €150,000 in funding from the European Research Council (ERC) The European Research Council (ERC) announced the first group of researchers who will receive ERC Proof of Concept Grants in 2025. Two scientists from UNIGE are among those selected. Pedro Herrera, Professor in the Department of Genetic…
Read MoreNestlé Partners with IBM Research to Use AI in New Packaging Developments
Nestlé R&D is partnering with IBM Research to develop new tools that leverage the power of Artificial Intelligence and deep tech to bring breakthrough innovations to life. This research collaboration has led to the development of a generative AI tool that can identify novel high-barrier packaging materials. Packaging helps to protect food and beverages while also preventing food waste. Nestlé tries to…
Read More